Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Perspective
|
Volume 11, Issue 3
|
pp. 1065–1068
Hallmarks of the cancer cell of origin: Comparisons with “energetic” cancer stem cells (e-CSCs)
Back to article
Figure 3
(3 of 3)
−
100%
+
Figure 3.
Therapeutic targeting of e-CSCs.
Experimentally, both an OXPHOS inhibitor (Diphenyleneiodonium; DPI) and a CDK4/6 (Ribociclib) inhibitor were effective in abrogating the 3D-propagation of e-CSCs.
